Innate Pharma IPHA
NASDAQ IPHA
$1.59 +0.05 (+3.25%)
As of: Nov 11, 2026 · 3:56 PM EST

Innate Pharma (IPHA) Net Cash Flow (2019)

Updated

Innate Pharma (IPHA) reported Net Cash Flow of -$61.41 million for the quarter ended Dec 31, 2025, compared with -$13.79 million a year earlier.

Analysis

Innate Pharma (IPHA) Net Cash Flow (2019) Analysis & Trends

For the year ended Dec 31, 2025, Innate Pharma posted Net Cash Flow of -$44.51 million.

  • By year, Net Cash Flow came in at -$4.01 million in the year ended Dec 31, 2024, -$15.03 million in the year ended Dec 31, 2023, -$20.14 million in the year ended Dec 31, 2022 and -$37.24 million in the year ended Dec 31, 2021.
  • The figure for the quarter ended Dec 31, 2025 ranks as the lowest quarterly Net Cash Flow since the quarter ended Dec 31, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -4.12 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -3.52 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 4.21 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.81 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.41 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -799.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 3.26 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 843.00 Mn
10 Innate Pharma 142.45 Mn -64.74 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 -70.31 Mn
API Access

Innate Pharma Net Cash Flow API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-cash-flow&ticker=IPHA&period=max&api_key=YOUR_API_KEY